Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01676415 · ClinicalTrials.gov registry record · Phase 4

Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

A Phase 4 study, sponsored by Northwestern University.

Terminated
Registry status
Phase 4
Development phase
9
Enrollment target

NCT01676415 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01676415, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.

TERMINATED
Registry status
Phase 4
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to determine the most effective route to administer steroids to patients with chronic sinusitis, specifically a type of chronic sinusitis not associated with nasal polyps (CRSsNP). The investigators would like to better understand whether orally administered steroids results in superior results when compared with nasally sprayed steroids. The investigators propose to test the hypothesis that for patients with radiographically proven CRSsNP, routine medical therapy consisting of a short course of systemic corticosteroids is superior to topical corticosteroids for relieving inflammation and the symptoms of CRS.

Interventions

  • DRUG Prednisone
  • DRUG Topical mometasone

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2012-08
Est. Completion 2016-08
Phase Phase 4

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT01676415

The ClinicalTrials.gov registry entry for NCT01676415 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.

NCT01676415 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01676415 about?

NCT01676415 is a clinical study titled "Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)". The purpose of this study is to determine the most effective route to administer steroids to patients with chronic sinusitis, specifically a type of chronic sinusitis not associated with nasal polyps (CRSsNP). The investigators would like to better understand whether orally administered steroids res...

What is the current status of trial NCT01676415?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2012-08. Estimated completion is 2016-08.

What interventions are being tested in trial NCT01676415?

The interventions under investigation include: Prednisone (DRUG), Topical mometasone (DRUG).

Who is sponsoring clinical trial NCT01676415?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.